FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer’s Disease5/11/23, 12:00 AMThe U.S. Food and Drug Administration (FDA) yesterday approved the expanded use of Rexulti (brexpipr...
Physical Activity Linked to Slower Cognitive Decline in Adults With Elevated Tau Levels8/12/21, 12:00 AM
Dementia at Younger Ages More Prevalent Than Previously Estimated, Meta-Analysis Suggests7/21/21, 12:00 AM